Why the study?
Does high-dose phenylephrine infusion improve hemodynamic parameters in a patient with hyperdynamic septic shock?
Does high-dose phenylephrine infusion improve hemodynamic parameters in a patient with hyperdynamic septic shock?
High-dose phenylephrine infusion may be an effective alternative to catecholamines for hemodynamic support in septic shock, particularly for patients prone to tachyarrhythmias.
May support hemodynamics in select septic shock cases; leaves open confirmation in prospective trials.
A 75-year-old man with hyperdynamic septic shock and vasodilation was successfully supported hemodynamically for 88.5 hours through the use of a continuous infusion of phenylephrine at dosages up to 360 micrograms/min. The only other vasoactive compound administered was dopamine at a dosage of 3.4 micrograms/kg/min. Hemodynamic evaluation indicated improvements in mean arterial pressure, cardiac output, and oxygen transport parameters during the period of hemodynamic support, which did not indicate a detrimental effect on perfusion of vital organs and tissues despite the use of this vasoconstrictor. Phenylephrine's pharmacologic properties may represent an advantage for its use as a vasoconstrictor over catecholamines such as norepinephrine and dopamine, particularly in patients who develop tachyarrhythmias with these agents. The pharmacology, dosage, and appropriate monitoring of therapy with phenylephrine in patients with septic shock are discussed.
No takes yet. Share an insight, caveat, or question.
Bonfiglio et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: